Using health technology assessment across the spectrum of health care delivery—from services to biotechnologies—could curb some of the $1 trillion in spending on defects in value in the US.

Value assessment will operate with the speed, flexibility and wisdom necessary to maximize that value. Achieving this future will require innovation, compromise, courage—and inclusion.

Jeroen Jansen, PhD, lead scientific advisor, Open-Source Value Project, Innovation and Value Initiative, discusses challenges with incorporating more novel concepts of value into value assessment.

To ensure that value assessment accounts for patient needs, we need a better understanding of the outcomes that are most important to patients, write authors from COVIA Health Solutions and the ...

Value assessment of new drugs and devices is gaining importance in the U.S. health care system. Pressure to do it right is accelerating.

Remember the buyer hierarchy The first step in assigning value to your customer list is to look at the big picture, keeping in mind the difference between customers and prospects. A house file will ...

Evidence-based assessments of the economic value of drugs can help control the escalating cost of drugs. So why doesn't the U.S. do this work and instead relies on other countries to do it?